A Study of APL-9 in Adults With Mild to Moderate ARDS Due to COVID-19
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at Fresno, California and other locations
- Dates
- study startedestimated completion
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Apellis Pharmaceuticals, Inc.
- ID
- NCT04402060
- Phase
- Phase 1/2
- Study Type
- Interventional
- Last Updated